MA55275A - Composés et compositions associées pour traiter une hypertension ou une insuffisance cardiaque - Google Patents
Composés et compositions associées pour traiter une hypertension ou une insuffisance cardiaqueInfo
- Publication number
- MA55275A MA55275A MA055275A MA55275A MA55275A MA 55275 A MA55275 A MA 55275A MA 055275 A MA055275 A MA 055275A MA 55275 A MA55275 A MA 55275A MA 55275 A MA55275 A MA 55275A
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- heart failure
- treating hypertension
- related compositions
- compositions
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/65—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfone or sulfoxide groups bound to the carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305286 | 2019-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA55275A true MA55275A (fr) | 2022-01-19 |
Family
ID=65818483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA055275A MA55275A (fr) | 2019-03-11 | 2020-03-11 | Composés et compositions associées pour traiter une hypertension ou une insuffisance cardiaque |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11345658B2 (fr) |
| EP (1) | EP3937924B1 (fr) |
| JP (1) | JP2022520494A (fr) |
| KR (1) | KR102401407B1 (fr) |
| CN (1) | CN113784710A (fr) |
| AR (1) | AR118302A1 (fr) |
| AU (1) | AU2020235216B2 (fr) |
| BR (1) | BR112021017158A2 (fr) |
| CA (1) | CA3129677C (fr) |
| EA (1) | EA202192421A1 (fr) |
| ES (1) | ES2965293T3 (fr) |
| IL (1) | IL285593B (fr) |
| MA (1) | MA55275A (fr) |
| MX (1) | MX2021011041A (fr) |
| TW (1) | TW202100146A (fr) |
| WO (1) | WO2020182870A1 (fr) |
| ZA (1) | ZA202107513B (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112142629B (zh) * | 2020-10-10 | 2021-09-14 | 西北工业大学 | 3-氨基磺酰基丙氨酸的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2773712B1 (fr) | 1998-01-16 | 2000-06-02 | Inst Nat Sante Rech Med | Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a |
| FR2858617A1 (fr) | 2003-08-06 | 2005-02-11 | Inst Nat Sante Rech Med | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
| EP2439192A1 (fr) | 2010-10-07 | 2012-04-11 | Quantum Genomics | Procédé pour la préparation de l'acide (3S,3S') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonique) |
-
2020
- 2020-03-09 TW TW109107735A patent/TW202100146A/zh unknown
- 2020-03-10 AR ARP200100650A patent/AR118302A1/es unknown
- 2020-03-11 MX MX2021011041A patent/MX2021011041A/es unknown
- 2020-03-11 CA CA3129677A patent/CA3129677C/fr active Active
- 2020-03-11 CN CN202080020321.1A patent/CN113784710A/zh active Pending
- 2020-03-11 KR KR1020217032594A patent/KR102401407B1/ko active IP Right Grant
- 2020-03-11 US US17/437,862 patent/US11345658B2/en active Active
- 2020-03-11 MA MA055275A patent/MA55275A/fr unknown
- 2020-03-11 AU AU2020235216A patent/AU2020235216B2/en active Active
- 2020-03-11 EP EP20708139.9A patent/EP3937924B1/fr active Active
- 2020-03-11 JP JP2021554368A patent/JP2022520494A/ja active Pending
- 2020-03-11 WO PCT/EP2020/056483 patent/WO2020182870A1/fr unknown
- 2020-03-11 EA EA202192421A patent/EA202192421A1/ru unknown
- 2020-03-11 IL IL285593A patent/IL285593B/en unknown
- 2020-03-11 ES ES20708139T patent/ES2965293T3/es active Active
- 2020-03-11 BR BR112021017158A patent/BR112021017158A2/pt unknown
-
2021
- 2021-10-06 ZA ZA2021/07513A patent/ZA202107513B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202107513B (en) | 2023-01-25 |
| EP3937924A1 (fr) | 2022-01-19 |
| JP2022520494A (ja) | 2022-03-30 |
| KR20210134037A (ko) | 2021-11-08 |
| AU2020235216A1 (en) | 2021-09-09 |
| CN113784710A (zh) | 2021-12-10 |
| AU2020235216B2 (en) | 2021-12-16 |
| MX2021011041A (es) | 2021-10-13 |
| ES2965293T3 (es) | 2024-04-12 |
| AR118302A1 (es) | 2021-09-29 |
| KR102401407B1 (ko) | 2022-05-23 |
| BR112021017158A2 (pt) | 2021-11-09 |
| US20220041548A1 (en) | 2022-02-10 |
| IL285593A (en) | 2021-09-30 |
| CA3129677C (fr) | 2023-01-03 |
| US11345658B2 (en) | 2022-05-31 |
| TW202100146A (zh) | 2021-01-01 |
| EA202192421A1 (ru) | 2021-12-22 |
| IL285593B (en) | 2022-07-01 |
| WO2020182870A1 (fr) | 2020-09-17 |
| CA3129677A1 (fr) | 2020-09-17 |
| EP3937924B1 (fr) | 2023-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA53095A (fr) | Composés et compositions pour traiter des états pathologiques associés à une activité de sting | |
| MA44734A (fr) | Composés et compositions destinés au traitement d'états associés à une activité de nlrp | |
| MA55138A (fr) | Composés et compositions pour traiter des états pathologiques associés à une activité de sting | |
| MA56193A (fr) | Composés et compositions pour traiter des états associés à une activité de sting | |
| MA52942A (fr) | Composés inhibiteurs d'oga | |
| MA55974A (fr) | Composés triaryles pour le traitement de maladies pd-l1 | |
| MA44729A (fr) | Composés et compositions pour traiter des états associés à une activité de nlrp | |
| MA52939A (fr) | Composés inhibiteurs d'oga | |
| MA54229A (fr) | Composés et compositions destinés au traitement d'états pathologiques associés à une activité de nlrp | |
| MA51669A (fr) | Composés | |
| EA201891143A1 (ru) | Пиперидиноновые агонисты формилпептидного рецептора 2 и формилпептидного рецептора 1 | |
| MA56032A (fr) | Composés, compositions et procédés d'utilisation | |
| EA202190272A1 (ru) | Дополнительно замещенные производные триазолохиноксалина | |
| EA202190271A1 (ru) | Замещенные триазолохиноксалиновые производные | |
| EA202091804A1 (ru) | Гетероциклил-замещенные оксадиазолопиридиновые производные для применения в качестве ингибиторов грелин-о-ацилтрансферазы (goat) | |
| DK4101454T3 (da) | Sammensætninger til behandling af hypertension | |
| MA55385A (fr) | Composés et leurs utilisations | |
| ZA202105111B (en) | Pharmaceutical composition for the treatment of pulmonary arterial hypertension | |
| MA55275A (fr) | Composés et compositions associées pour traiter une hypertension ou une insuffisance cardiaque | |
| MA43848A (fr) | Composés deutérés pour le traitement d'hémopathies malignes, compositions et procédés associés | |
| MA56186A (fr) | Composés pour le traitement d'une maladie respiratoire | |
| IT201900019391A1 (it) | Composizione per la riduzione del rischio cardiovascolare | |
| MA52934A (fr) | Composés inhibiteurs de l'oga | |
| MA52936A (fr) | Composés inhibiteurs d'oga | |
| MA52937A (fr) | Composés inhibiteurs d'oga |